OpenEvidence Secures $200 Million to Develop AI for Healthcare Solutions

OpenEvidence, a startup company developing AI solutions for healthcare, has raised $200 million, achieving a $6 billion valuation, rivaling giants like ChatGPT in specialized applications.

• On Monday, OpenEvidence plans to announce its successful funding round of $200 million, pushing its valuation (finance) to an impressive $6 billion.
• The companys software, often compared to ChatGPT for doctors, aims to provide specialized artificial intelligence solutions within the healthcare sector.
• Investors are increasingly drawn to companies like OpenEvidence, demonstrating a growing interest in targeted artificial intelligence applications beyond major players.